Abstract/Full Text (subscription or payment may be required)
Breast Cancer Patients Do Not Overreact to Genetic Testing
THURSDAY, Jan. 17, 2019 (HealthDay News) — Among breast cancer patients, more extensive genetic testing is not associated with increased cancer worry, according to a study recently published in JCO Precision Oncology.
Abstract/Full Text (subscription or payment may be required)
Coronary Artery Calcium May Help Predict CVD in South Asians
WEDNESDAY, Jan. 16, 2019 (HealthDay News) — The incidence and progression of coronary artery calcium (CAC) in South Asians may be an important prognostic marker of cardiovascular disease, according to a study published online Jan. 11 in the Journal of the American Heart Association.
High Levels of Activity, Motor Ability Linked to Better Cognition
WEDNESDAY, Jan. 16, 2019 (HealthDay News) — In older adults, higher levels of total daily activity and better motor abilities are associated with better cognition, according to a study published online Jan. 16 in Neurology.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Adoption of Advanced Health IT Capabilities Inconsistent
WEDNESDAY, Jan. 16, 2019 (HealthDay News) — Adoption of advanced health information technology (HIT) capabilities is inconsistent across health care systems, with electronic health record (EHR) standardization being the strongest predictor of advanced capabilities, according to a study published in the January issue of the American Journal of Managed Care.
Complications Higher Than Expected for Invasive Lung Tests
WEDNESDAY, Jan. 16, 2019 (HealthDay News) — The rates of complications after invasive diagnostic procedures for lung abnormalities are higher in the community setting than in clinical trials, according to a study published online Jan. 14 in JAMA Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Breakdown of Blood-Brain Barrier May Drive Dementia
TUESDAY, Jan. 15, 2019 (HealthDay News) — Breakdown of the blood-brain barrier (BBB) may be an early biomarker of cognitive dysfunction, independent of amyloid or tau marker status, according to a study published online Jan. 14 in Nature Medicine.
Abstract/Full Text (subscription or payment may be required)
Stem Cell Transplant Slows Progression of Multiple Sclerosis
TUESDAY, Jan. 15, 2019 (HealthDay News) — For patients with relapsing-remitting multiple sclerosis (MS), nonmyeloablative hematopoietic stem cell transplantation (HCST) is associated with prolonged time to disease progression compared with disease-modifying therapy (DMT), according to a study published in the Jan. 15 issue of the Journal of the American Medical Association.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Congo Ebola Outbreak Now Second Worst in History
Study IDs Predictors of Biomechanical Function in Patients With OA Undergoing Hip Replacement 
Birmingham Hip Resurfacing Safe, Effective Over 15 Years 
Medial Temporal Lobectomy Aids Seizure Outcomes in Epilepsy 
Bausch + Lomb Issues Recall of enVista Lenses Used in Cataract Surgery 
Preop Macular Thickness May Be Marker of Postop Delirium in Seniors 
NeuroSAFE Improves Erectile Function After Radical Prostatectomy 
Longer PSA Monitoring in Patients With Persistent PSA May Reduce Overtreatment 
Use of Parallel Transmit 7T MRI Changes Management for Epilepsy Surgery 
